HLA matching for organ transplantation... Why not?

International Journal of Immunogenetics

Volumn 37, Issue 5, 2010, Pages 323-327

  Cecka, J M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT SURVIVAL; HLA MATCHING; HUMAN; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ORGAN TRANSPLANTATION;

EID: 78651086511     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00957.x     Document Type: Review

References (14)

1. Claas, F.H., Rahmel, A. & Doxiadis, I.I. (2009) Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation, 88, 447.
2. Danovitch, G.M. & Cecka, J.M. (2003) Allocation of deceased donor kidneys: past, present and future. American Journal of Kidney Diseases, 42, 882.
3. Doxiadis, I.I., de Fijter, J.W., Mallat, M.J., Haasnoot, G.W., Ringers, J., Persijn, G.G. & Claas, F.H. (2007) Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation, 83, 1207.
4. Edwards, E.B., Bennett, L. & Cecka, J.M. (1997) The effect of HLA matching on the relative risk of mortality for kidney recipients: a comparison of the mortality risk posttransplant to the mortality risk of remaining on the waiting list. Transplantation, 64, 1274.
5. Eurotransplant International Foundation (2008) Eurotransplant International Foundation Annual Report 2008. http://www.eurotransplant.org/files/annual_report/ar_2008.pdf [Accessed on 01 June 2010].
6. Gritsch, H.A., Veale, J., Leichtman, A.B., Guidinger, M., Magee, J.C., McDonald, R., Harmon, W., Delmonico, F., Ettenger, R. & Cecka, J.M. (2008) Should pediatric patients wait for HLADR matched renal transplants? American Journal of Transplantation, 8, 2056.
7. Higgins, R.M., Johnson, R., Jones, M.N.A. & Rudge, C. (2005) Efficiency is a legitimate consideration in equitable distribution of cadaveric transplant: development of an efficiency-equality model of equity. Transplantation Proceedings, 37, 595.
8. Mickey, M.R., Kreisler, M., Albert, E.D., Tanaka, N. & Terasaki, P.I. (1971) Analysis of HLA incompatibility in human renal transplants. Tissue Antigens, 2, 57.
9. Opelz, G., Wujciak, T., Dohler, B., Scherer, S.&Mytelineos, J. (1999) HLA compatibility and organ transplant survival. Collaborative Transplant Study. Reviews in Immunogenetics, 1, 334.
10. Takemoto, S., Terasaki, P.I., Cecka, J.M., Cho, Y. & Gjertson, D.W. (1992) Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. New England Journal of Medicine, 327, 834.
11. Takemoto, S.K., Terasaki, P.I., Gjertson, D.W. & Cecka, J.M. (2000) Twelve years experience with shipping HLA-matched cadaver kidneys for transplantation. New England Journal of Medicine, 343, 1078.
12. Terasaki, P.I., Gjertson, D.W., Cecka, J.M., Takemoto, S. & Cho, Y.W. (1997) Significance of the donor age effect on kidney transplants. Clinical Transplantation, 11, 366.
13. Tiwari, J.L. (1986) Review: kidney transplantation and HLA. In: Clinical Kidney Transplants 1985 (ed. P.I. Terasaki), pp. 233-255, UCLA Tissue Typing Laboratory, Los Angeles.
14. US Department of Health and Human Services (2008) OPTN / SRTR Annual Report. http://optn.transplant.hrsa.gov/ar2008/504c_rec-mm_ki.htm [Accessed on 1 June 2010].